QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=6417976627838B071D7BFEF3B90DCE89;jsessionid=875BB669CE56402ED39489983E744C9F;jsessionid=0B65F622F6B7E79893BE698E0A6D6AB9;jsessionid=97EFDC32656473E2869E2FC89FEEE58E;jsessionid=16A119D2B1F68AD78A741421E88220E7;jsessionid=ADEA59E74520F7E4133F63C6495B8DFF (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=6417976627838B071D7BFEF3B90DCE89;jsessionid=875BB669CE56402ED39489983E744C9F;jsessionid=0B65F622F6B7E79893BE698E0A6D6AB9;jsessionid=97EFDC32656473E2869E2FC89FEEE58E;jsessionid=16A119D2B1F68AD78A741421E88220E7;jsessionid=ADEA59E74520F7E4133F63C6495B8DFF